![XLV XLV](https://data.pdbj.org/pdbjplus/data/cc/svg/XLV.svg) | XLV | Name: | 3,4-dimethyl-1,2-oxazol-5-amine | Formula: | C5 H8 N2 O | SMILES: | n1oc(N)c(C)c1C | InChi: | InChI=1S/C5H8N2O/c1-3-4(2)7-8-5(3)6/h6H2,1-2H3 | Definition date: | 2020-12-18 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 3,4-dimethyl-1,2-oxazol-5-amine |
|
![XLY XLY](https://data.pdbj.org/pdbjplus/data/cc/svg/XLY.svg) | XLY | Name: | (3R)-3-methyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one | Formula: | C10 H12 N2 O | SMILES: | N2C(c1ccccc1NCC2C)=O | InChi: | InChI=1S/C10H12N2O/c1-7-6-11-9-5-3-2-4-8(9)10(13)12-7/h2-5,7,11H,6H2,1H3,(H,12,13) | Definition date: | 2020-12-18 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | (3R)-3-methyl-1,2,3,4-tetrahydro-5H-1,4-benzodiazepin-5-one |
|
![XM4 XM4](https://data.pdbj.org/pdbjplus/data/cc/svg/XM4.svg) | XM4 | Name: | N-(4-chloro-2-methylphenyl)acetamide | Formula: | C9 H10 Cl N O | SMILES: | N(c1ccc(cc1C)Cl)C(C)=O | InChi: | InChI=1S/C9H10ClNO/c1-6-5-8(10)3-4-9(6)11-7(2)12/h3-5H,1-2H3,(H,11,12) | Definition date: | 2020-12-18 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | N-(4-chloro-2-methylphenyl)acetamide |
|
![374 374](https://data.pdbj.org/pdbjplus/data/cc/svg/374.svg) | 374 | Name: | (2-fluoranyl-4-methoxy-phenyl)-[(3~{R},5~{R})-4-(2-fluoranyl-4-methoxy-phenyl)carbonyl-3,5-dimethyl-piperazin-1-yl]methanone | Formula: | C22 H24 F2 N2 O4 | SMILES: | COc1ccc(c(F)c1)C(=O)N2C[CH](C)N([CH](C)C2)C(=O)c3ccc(OC)cc3F | InChi: | InChI=1S/C22H24F2N2O4/c1-13-11-25(21(27)17-7-5-15(29-3)9-19(17)23)12-14(2)26(13)22(28)18-8-6-16(30-4)10-20(18)24/h5-10,13-14H,11-12H2,1-4H3/t13-,14-/m1/s1 | Definition date: | 2020-03-06 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | (2-fluoranyl-4-methoxy-phenyl)-[(3~{R},5~{R})-4-(2-fluoranyl-4-methoxy-phenyl)carbonyl-3,5-dimethyl-piperazin-1-yl]methanone |
|
![EL9 EL9](https://data.pdbj.org/pdbjplus/data/cc/svg/EL9.svg) | EL9 | Name: | cyclometalated-carbene platinum(II) complex | Formula: | C20 H15 F2 N4 Pt | SMILES: | CN1CN(C=C1)c2ccccn2.Fc3cc(F)c(c([Pt])c3)c4ccccn4 | InChi: | InChI=1S/C11H6F2N.C9H10N3.Pt/c12-8-4-5-9(10(13)7-8)11-3-1-2-6-14-11 | Definition date: | 2020-01-10 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 |
|
![EN3 EN3](https://data.pdbj.org/pdbjplus/data/cc/svg/EN3.svg) | EN3 | Name: | (E)-15,22-Dioxa-4,11-diaza-5(2,5)-thiadiazola-10(3,6)-pyridazina-1,14(1,3)-dibenzenacyclodocosaphan-18-ene-3,12-dione | Formula: | C32 H34 N6 O4 S | SMILES: | O=C1Cc2cccc(OCCC=CCCOc3cccc(CC(=O)Nc4ccc(CCCCc5sc(N1)nn5)nn4)c3)c2 | InChi: | InChI=1S/C32H34N6O4S/c39-29-21-23-9-7-12-26(19-23)41-17-5-1-2-6-18-42-27-13-8-10-24(20-27)22-30(40)34-32-38-37-31(43-32)14-4-3-11-25-15-16-28(33-29)36-35-25/h1-2,7-10,12-13,15-16,19-20H,3-6,11,14,17-18,21-22H2,(H,33,36,39)(H,34,38,40)/b2-1+ | Definition date: | 2020-01-16 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 |
|
![EOR EOR](https://data.pdbj.org/pdbjplus/data/cc/svg/EOR.svg) | EOR | Name: | 2-[[6-(dimethylamino)-1,3-benzodioxol-5-yl]sulfanyl]-1-[2-(2,2-dimethylpropylamino)ethyl]imidazo[4,5-c]pyridin-4-amine | Formula: | C22 H30 N6 O2 S | SMILES: | CN(C)c1cc2OCOc2cc1Sc3nc4c(N)nccc4n3CCNCC(C)(C)C | InChi: | InChI=1S/C22H30N6O2S/c1-22(2,3)12-24-8-9-28-14-6-7-25-20(23)19(14)26-21(28)31-18-11-17-16(29-13-30-17)10-15(18)27(4)5/h6-7,10-11,24H,8-9,12-13H2,1-5H3,(H2,23,25) | Definition date: | 2020-01-17 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 2-[[6-(dimethylamino)-1,3-benzodioxol-5-yl]sulfanyl]-1-[2-(2,2-dimethylpropylamino)ethyl]imidazo[4,5-c]pyridin-4-amine |
|
![GZ9 GZ9](https://data.pdbj.org/pdbjplus/data/cc/svg/GZ9.svg) | GZ9 | Name: | (2S)-2-[2-(cyclohexylcarbamoylamino)-3,6-dimethyl-5-(5-methyl-3,4-dihydro-2H-chromen-6-yl)pyridin-4-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid | Formula: | C30 H41 N3 O5 | SMILES: | Cc1nc(NC(=O)NC2CCCCC2)c(C)c([CH](OC(C)(C)C)C(O)=O)c1c3ccc4OCCCc4c3C | InChi: | InChI=1S/C30H41N3O5/c1-17-21-13-10-16-37-23(21)15-14-22(17)25-19(3)31-27(33-29(36)32-20-11-8-7-9-12-20)18(2)24(25)26(28(34)35)38-30(4,5)6/h14-15,20,26H,7-13,16H2,1-6H3,(H,34,35)(H2,31,32,33,36)/t26-/m0/s1 | Definition date: | 2020-10-09 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | (2~{S})-2-[2-(cyclohexylcarbamoylamino)-3,6-dimethyl-5-(5-methyl-3,4-dihydro-2~{H}-chromen-6-yl)pyridin-4-yl]-2-[(2-methylpropan-2-yl)oxy]ethanoic acid |
|
![H2L H2L](https://data.pdbj.org/pdbjplus/data/cc/svg/H2L.svg) | H2L | Name: | 1-[3-[2-(1H-indol-3-yl)ethylsulfamoyl]phenyl]-3-(1,3-thiazol-2-yl)urea | Formula: | C20 H19 N5 O3 S2 | SMILES: | O=C(Nc1sccn1)Nc2cccc(c2)[S](=O)(=O)NCCc3c[nH]c4ccccc34 | InChi: | InChI=1S/C20H19N5O3S2/c26-19(25-20-21-10-11-29-20)24-15-4-3-5-16(12-15)30(27,28)23-9-8-14-13-22-18-7-2-1-6-17(14)18/h1-7,10-13,22-23H,8-9H2,(H2,21,24,25,26) | Definition date: | 2020-10-26 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 1-[3-[2-(1~{H}-indol-3-yl)ethylsulfamoyl]phenyl]-3-(1,3-thiazol-2-yl)urea |
|
![H2R H2R](https://data.pdbj.org/pdbjplus/data/cc/svg/H2R.svg) | H2R | Name: | N-pyridin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide | Formula: | C24 H23 F3 N4 O2 | SMILES: | FC(F)(F)c1ccc(Oc2cccc(CC3CCN(CC3)C(=O)Nc4cccnc4)c2)nc1 | InChi: | InChI=1S/C24H23F3N4O2/c25-24(26,27)19-6-7-22(29-15-19)33-21-5-1-3-18(14-21)13-17-8-11-31(12-9-17)23(32)30-20-4-2-10-28-16-20/h1-7,10,14-17H,8-9,11-13H2,(H,30,32) | Definition date: | 2020-10-27 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | ~{N}-pyridin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide |
|
![H4L H4L](https://data.pdbj.org/pdbjplus/data/cc/svg/H4L.svg) | H4L | Name: | 3-[4-[2-[3-[[2-[(1~{S})-1-oxidanylethyl]imidazol-1-yl]methyl]-1,2-oxazol-5-yl]ethynyl]phenyl]propan-1-ol | Formula: | C20 H21 N3 O3 | SMILES: | C[CH](O)c1nccn1Cc2cc(on2)C#Cc3ccc(CCCO)cc3 | InChi: | InChI=1S/C20H21N3O3/c1-15(25)20-21-10-11-23(20)14-18-13-19(26-22-18)9-8-17-6-4-16(5-7-17)3-2-12-24/h4-7,10-11,13,15,24-25H,2-3,12,14H2,1H3/t15-/m0/s1 | Definition date: | 2020-11-05 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 3-[4-[2-[3-[[2-[(1~{S})-1-oxidanylethyl]imidazol-1-yl]methyl]-1,2-oxazol-5-yl]ethynyl]phenyl]propan-1-ol |
|
![H4O H4O](https://data.pdbj.org/pdbjplus/data/cc/svg/H4O.svg) | H4O | Name: | 5-[4-[3-[[2-[(1~{S})-1-oxidanylethyl]imidazol-1-yl]methyl]-1,2-oxazol-5-yl]phenyl]pent-4-yn-1-ol | Formula: | C20 H21 N3 O3 | SMILES: | C[CH](O)c1nccn1Cc2cc(on2)c3ccc(cc3)C#CCCCO | InChi: | InChI=1S/C20H21N3O3/c1-15(25)20-21-10-11-23(20)14-18-13-19(26-22-18)17-8-6-16(7-9-17)5-3-2-4-12-24/h6-11,13,15,24-25H,2,4,12,14H2,1H3/t15-/m0/s1 | Definition date: | 2020-11-05 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 5-[4-[3-[[2-[(1~{S})-1-oxidanylethyl]imidazol-1-yl]methyl]-1,2-oxazol-5-yl]phenyl]pent-4-yn-1-ol |
|
![H4R H4R](https://data.pdbj.org/pdbjplus/data/cc/svg/H4R.svg) | H4R | Name: | 4-[(1~{R},5~{S})-6-[2-[4-[3-[[2-[(1~{S})-1-oxidanylethyl]imidazol-1-yl]methyl]-1,2-oxazol-5-yl]phenyl]ethynyl]-3-azabicyclo[3.1.0]hexan-3-yl]butanoic acid | Formula: | C26 H28 N4 O4 | SMILES: | C[CH](O)c1nccn1Cc2cc(on2)c3ccc(cc3)C#CC4[CH]5CN(CCCC(O)=O)C[CH]45 | InChi: | InChI=1S/C26H28N4O4/c1-17(31)26-27-10-12-30(26)14-20-13-24(34-28-20)19-7-4-18(5-8-19)6-9-21-22-15-29(16-23(21)22)11-2-3-25(32)33/h4-5,7-8,10,12-13,17,21-23,31H,2-3,11,14-16H2,1H3,(H,32,33)/t17-,21-,22-,23+/m0/s1 | Definition date: | 2020-11-05 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 4-[(1~{R},5~{S})-6-[2-[4-[3-[[2-[(1~{S})-1-oxidanylethyl]imidazol-1-yl]methyl]-1,2-oxazol-5-yl]phenyl]ethynyl]-3-azabicyclo[3.1.0]hexan-3-yl]butanoic acid |
|
![OQ5 OQ5](https://data.pdbj.org/pdbjplus/data/cc/svg/OQ5.svg) | OQ5 | Name: | 20-[[(2~{S})-5-[2-[2-[2-[2-[2-[2-(diethylamino)-2-oxidanylidene-ethoxy]ethoxy]ethylamino]-2-oxidanylidene-ethoxy]ethoxy]ethylamino]-1-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-20-oxidanylidene-icosanoic acid | Formula: | C41 H76 N4 O12 | SMILES: | CCN(CC)C(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[CH](NC(=O)CCCCCCCCCCCCCCCCCCC(O)=O)C(O)=O | InChi: | InChI=1S/C41H76N4O12/c1-3-45(4-2)39(49)34-57-32-30-55-28-26-43-38(48)33-56-31-29-54-27-25-42-36(46)24-23-35(41(52)53)44-37(47)21-19-17-15-13-11-9-7-5-6-8-10-12-14-16-18-20-22-40(50)51/h35H,3-34H2,1-2H3,(H,42,46)(H,43,48)(H,44,47)(H,50,51)(H,52,53)/t35-/m0/s1 | Definition date: | 2020-03-27 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 20-[[(2~{S})-5-[2-[2-[2-[2-[2-[2-(diethylamino)-2-oxidanylidene-ethoxy]ethoxy]ethylamino]-2-oxidanylidene-ethoxy]ethoxy]ethylamino]-1-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]amino]-20-oxidanylidene-icosanoic acid |
|
![F0L F0L](https://data.pdbj.org/pdbjplus/data/cc/svg/F0L.svg) | F0L | Name: | nickel-sirohydrochlorin | Formula: | C42 H44 N4 Ni O16 | SMILES: | C[C]1(CC(O)=O)[CH](CCC(O)=O)C2=NC1=Cc3n4[Ni++][N]5C(=CC6=NC(=Cc4c(CCC(O)=O)c3CC(O)=O)C(=C6CC(O)=O)CCC(O)=O)[CH](CCC(O)=O)[C](C)(CC(O)=O)C5=C2 | InChi: | InChI=1S/C42H46N4O16.Ni/c1-41(17-39(59)60)23(5-9-35(51)52)29-14-27-21(11-37(55)56)19(3-7-33(47)48)25(43-27)13-26-20(4-8-34(49)50)22(12-38(57)58)28(44-26)15-31-42(2,18-40(61)62)24(6-10-36(53)54)30(46-31)16-32(41)45-29 | Definition date: | 2020-03-05 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 |
|
![F0O F0O](https://data.pdbj.org/pdbjplus/data/cc/svg/F0O.svg) | F0O | Name: | 2-chloranyl-1,3-thiazole-5-carboxylic acid | Formula: | C4 H2 Cl N O2 S | SMILES: | OC(=O)c1sc(Cl)nc1 | InChi: | InChI=1S/C4H2ClNO2S/c5-4-6-1-2(9-4)3(7)8/h1H,(H,7,8) | Definition date: | 2020-03-05 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 2-chloranyl-1,3-thiazole-5-carboxylic acid |
|
![F0X F0X](https://data.pdbj.org/pdbjplus/data/cc/svg/F0X.svg) | F0X | Name: | cobalt-sirohydrochlorin | Formula: | C42 H44 Co N4 O16 | SMILES: | C[C]1(CC(O)=O)[CH](CCC(O)=O)C2=NC1=Cc3n4[Co++][N]5C(=CC6=NC(=Cc4c(CCC(O)=O)c3CC(O)=O)C(=C6CC(O)=O)CCC(O)=O)[CH](CCC(O)=O)[C](C)(CC(O)=O)C5=C2 | InChi: | InChI=1S/C42H46N4O16.Co/c1-41(17-39(59)60)23(5-9-35(51)52)29-14-27-21(11-37(55)56)19(3-7-33(47)48)25(43-27)13-26-20(4-8-34(49)50)22(12-38(57)58)28(44-26)15-31-42(2,18-40(61)62)24(6-10-36(53)54)30(46-31)16-32(41)45-29 | Definition date: | 2020-03-11 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 |
|
![QFT QFT](https://data.pdbj.org/pdbjplus/data/cc/svg/QFT.svg) | QFT | Name: | 2-fluoranyl-5-nitro-phenol | Formula: | C6 H4 F N O3 | SMILES: | Oc1cc(ccc1F)[N](=O)=O | InChi: | InChI=1S/C6H4FNO3/c7-5-2-1-4(8(10)11)3-6(5)9/h1-3,9H | Definition date: | 2020-06-15 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 2-fluoranyl-5-nitro-phenol |
|
![QFZ QFZ](https://data.pdbj.org/pdbjplus/data/cc/svg/QFZ.svg) | QFZ | Name: | 2,3,4,5,6-pentakis(fluoranyl)phenol | Formula: | C6 H F5 O | SMILES: | Oc1c(F)c(F)c(F)c(F)c1F | InChi: | InChI=1S/C6HF5O/c7-1-2(8)4(10)6(12)5(11)3(1)9/h12H | Definition date: | 2020-06-15 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 2,3,4,5,6-pentakis(fluoranyl)phenol |
|
![QKT QKT](https://data.pdbj.org/pdbjplus/data/cc/svg/QKT.svg) | QKT | Name: | Diperodon (S-enantiomer) | Formula: | C22 H27 N3 O4 | SMILES: | O=C(Nc1ccccc1)OC[CH](CN2CCCCC2)OC(=O)Nc3ccccc3 | InChi: | InChI=1S/C22H27N3O4/c26-21(23-18-10-4-1-5-11-18)28-17-20(16-25-14-8-3-9-15-25)29-22(27)24-19-12-6-2-7-13-19/h1-2,4-7,10-13,20H,3,8-9,14-17H2,(H,23,26)(H,24,27)/t20-/m0/s1 | Definition date: | 2020-06-23 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | [(2~{S})-2-(phenylcarbamoyloxy)-3-piperidin-1-yl-propyl] ~{N}-phenylcarbamate |
|
![ODQ ODQ](https://data.pdbj.org/pdbjplus/data/cc/svg/ODQ.svg) | ODQ | Name: | (3~{R})-3,4-dimethyl-3-propyl-1~{H}-1,4-benzodiazepine-2,5-dione | Formula: | C14 H18 N2 O2 | SMILES: | CCC[C]1(C)N(C)C(=O)c2ccccc2NC1=O | InChi: | InChI=1S/C14H18N2O2/c1-4-9-14(2)13(18)15-11-8-6-5-7-10(11)12(17)16(14)3/h5-8H,4,9H2,1-3H3,(H,15,18)/t14-/m1/s1 | Definition date: | 2020-02-27 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | (3~{R})-3,4-dimethyl-3-propyl-1~{H}-1,4-benzodiazepine-2,5-dione |
|
![ODW ODW](https://data.pdbj.org/pdbjplus/data/cc/svg/ODW.svg) | ODW | Name: | (1~{R},2~{S},3~{S},4~{R},5~{R})-4-(hydroxymethyl)-8-azabicyclo[3.2.1]octane-1,2,3-triol | Formula: | C8 H15 N O4 | SMILES: | OC[CH]1[CH](O)[CH](O)[C]2(O)CC[CH]1N2 | InChi: | InChI=1S/C8H15NO4/c10-3-4-5-1-2-8(13,9-5)7(12)6(4)11/h4-7,9-13H,1-3H2/t4-,5+,6-,7-,8+/m0/s1 | Synonyms: | galacto-noeurostegine | Definition date: | 2020-02-28 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | (1~{R},2~{S},3~{S},4~{R},5~{R})-4-(hydroxymethyl)-8-azabicyclo[3.2.1]octane-1,2,3-triol |
|
![OJB OJB](https://data.pdbj.org/pdbjplus/data/cc/svg/OJB.svg) | OJB | Name: | 5-[(2~{R},3~{R},4~{R},5~{R},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-~{N}-[3-(propanoylamino)propyl]pentanamide | Formula: | C19 H35 N3 O8 | SMILES: | CCC(=O)NCCCNC(=O)CCCCO[CH]1O[CH](CO)[CH](O)[CH](O)[CH]1NC(C)=O | InChi: | InChI=1S/C19H35N3O8/c1-3-14(25)20-8-6-9-21-15(26)7-4-5-10-29-19-16(22-12(2)24)18(28)17(27)13(11-23)30-19/h13,16-19,23,27-28H,3-11H2,1-2H3,(H,20,25)(H,21,26)(H,22,24)/t13-,16-,17+,18-,19-/m1/s1 | Definition date: | 2020-03-13 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 5-[(2~{R},3~{R},4~{R},5~{R},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-~{N}-[3-(propanoylamino)propyl]pentanamide |
|
![Q39 Q39](https://data.pdbj.org/pdbjplus/data/cc/svg/Q39.svg) | Q39 | Name: | 1-[3-(2-methyl-4-thiophen-2-yl-1,3-thiazol-5-yl)propanoyl]piperidine-4-carboxamide | Formula: | C17 H21 N3 O2 S2 | SMILES: | Cc1sc(CCC(=O)N2CCC(CC2)C(N)=O)c(n1)c3sccc3 | InChi: | InChI=1S/C17H21N3O2S2/c1-11-19-16(13-3-2-10-23-13)14(24-11)4-5-15(21)20-8-6-12(7-9-20)17(18)22/h2-3,10,12H,4-9H2,1H3,(H2,18,22) | Definition date: | 2020-08-14 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | 1-[3-(2-methyl-4-thiophen-2-yl-1,3-thiazol-5-yl)propanoyl]piperidine-4-carboxamide |
|
![QAK QAK](https://data.pdbj.org/pdbjplus/data/cc/svg/QAK.svg) | QAK | Name: | (6~{R},10~{S},14~{R},19~{R},23~{S},24~{E},27~{S},28~{E})-2,6,10,14,19,23,27,31-octamethyldotriaconta-24,28-dien-2-ol | Formula: | C40 H78 O | SMILES: | CC(C)CC=C[CH](C)CC=C[CH](C)CCC[CH](C)CCCC[CH](C)CCC[CH](C)CCC[CH](C)CCCC(C)(C)O | InChi: | InChI=1S/C40H78O/c1-33(2)19-13-22-36(5)25-16-28-37(6)26-14-23-34(3)20-11-12-21-35(4)24-15-27-38(7)29-17-30-39(8)31-18-32-40(9,10)41/h13,16,22,28,33-39,41H,11-12,14-15,17-21,23-27,29-32H2,1-10H3/b22-13+,28-16+/t34-,35-,36-,37+,38+,39-/m1/s1 | Definition date: | 2020-05-30 | Last modified: | 2021-01-08 | Release date: | 2021-01-13 | Identifier: | (6~{R},10~{S},14~{R},19~{R},23~{S},24~{E},27~{S},28~{E})-2,6,10,14,19,23,27,31-octamethyldotriaconta-24,28-dien-2-ol |
|